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Old age and the passage of time teach all things
[Sophocles]
To me, old age is always fifteen years older than I am
[Bernard Baruch]
Article p. 143
As a consequence of public health measures
and medical innovations, the average lifespan in
even the most industrialized nations continues to
increase in an impressive manner. In the United
States, for example, from 1960 to 2000 life expect-
ancy for newborns increased by 7 years, represent-
ing nearly a 10% gain [1]. Since atherosclerosis
remains predominantly a disease of older individu-
als, more and more elderly patients can be expect-
ed to require medical care for coronary artery dis-
ease as the population ages. Unfortunately, older
individuals traditionally have not been included in
prospective trials examining treatment strategies
for coronary disease, leaving us with limited infor-
mation on how best to treat this ever-growing pa-
tient subgroup.
Coronary angioplasty in the elderly
Since the inception of coronary angioplasty,
registry-based analyses consistently have identified
advanced age as a strong independent risk factor for
procedural mortality. Although in-hospital outcomes
have improved among all age groups with enhance-
ments in angioplasty equipment, techniques, and ad-
juvant medical therapies, patient age remains
a strong predictor of in-hospital death following per-
cutaneous coronary intervention (PCI) [2, 3].
In everyday practice, given the increased pro-
cedural risks, there is often greater reluctance
among physicians to refer older individuals for PCI.
Despite these heightened risks, however, observa-
tional data suggests that PCI for elderly patients is
potentially beneficial across the spectrum of coro-
nary syndromes. Among elderly individuals with
stable angina, PCI appears to confer equivalent
improvements in quality of life compared to younger
individuals [4]. In the setting of acute coronary syn-
dromes, older patients enrolled in the TIMI-18 tri-
al benefited from an early invasive strategy includ-
ing angioplasty rather than a strategy of initial con-
servative management [5]. Likewise, in the setting
of acute ST segment elevation myocardial infarc-
tion, primary PCI is associated with an even great-
er relative reduction in mortality compared to
thrombolytic therapy in elderly patients than among
younger individuals [6].
Current study
In light of improving PCI outcomes, the study
by Sukiennik et al. [7] that appears in the current
issue of Cardiology Journal provides additional in-
sights into contemporary real world experience
with PCI among older individuals. One thousand
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consecutive patients who underwent PCI at a sin-
gle center were dichotomized into those < 70 years
old versus those ‡ 70 years of age. Not surprising-
ly, the authors found that patients over age 70 had
more comorbid conditions than younger patients,
including diabetes, hypertension, a history of conges-
tive heart failure, and prior stroke. Multivessel cor-
onary disease was more common among older indi-
viduals, and older patients were more likely to un-
dergo PCI in the setting of an acute coronary
syndrome or cardiogenic shock. PCI was more diffi-
cult from a technical standpoint among older individ-
uals, as inferred by the need for greater amounts of
fluoroscopy time and radiographic contrast during the
procedure. Primary stenting was also less common
among older patients as was overall stent use, which
likewise implies less favorable anatomy for PCI. Even
after adjustment for other comorbidities, in-hospital
mortality remained approximately 3-fold greater
among older compared to younger individuals.
These findings are similar to those of a larger
recently published registry of over 82,000 consec-
utive patients who underwent PCI in New York
State [8]. Within this cohort, age represented the
strongest independent clinical predictor of in-hos-
pital death following PCI. Mortality rates following
elective PCI rose from 0.1% among individuals
younger than 60 years old to 1.1% among patients
> 80 years old. A similar 10-fold increase in mor-
tality was noted following emergency PCI, with in-
hospital mortality increasing from 1.0% for patients
< 60 years old to 11.5% for patients > 80 years old.
The authors speculated that the age-related in-
crease in adverse procedural outcomes was at least
in part related to greater technical difficulties in
performing PCI in the elderly population, as reflect-
ed by greater likelihoods of peripheral vascular dis-
ease and aorto-iliac tortuosity (which increase the
difficulty of accessing the coronary circulation) and
greater coronary calcification and extent of coronary
disease (which reduce the likelihood of procedural
success) among older individuals.
Clinical implications
How might the findings of these recent stud-
ies of PCI affect the clinical decision-making proc-
ess for a physician attempting to optimize care for
an elderly patient with symptomatic coronary artery
disease? Foremost, it should be kept in mind that
these PCI registry-based reports examined only
a selected group of patients, namely those who had
already been referred by their physicians to undergo
PCI. These studies therefore cannot provide infor-
mation regarding the relative merits of PCI versus
either medical therapy or bypass surgery among
elderly patients. Because of the potential risks as-
sociated with more invasive procedures, physicians
often remain hesitant to recommend PCI for older
patients, often favoring conservative medical ther-
apy. As a result, older patients may not be referred
for PCI until later in the course of their disease,
rendering PCI more technically challenging and
risky than it may have been had the procedure been
performed at an earlier stage.
Presumptive evidence for such a referral de-
lay is present in the Sukiennik study [7], as a sig-
nificantly higher proportion of elderly compared to
younger patients underwent PCI in an urgent rather
than elective setting. While intriguing to speculate,
it remains uncertain as to whether outcomes among
selected elderly patients might improve if there was
less hesitancy to refer these individuals for elec-
tive PCI earlier, rather than waiting for the onset
of unstable symptoms. This is especially true in
light of the dramatic increase in mortality rates
among older patients when PCI is performed on an
acute rather than elective basis.
As with PCI, the risks of coronary bypass sur-
gery also increase with patient age [9]. For individ-
uals with more extensive coronary disease, bypass
grafting permits a higher likelihood of complete cor-
onary revascularization than PCI, which may be as-
sociated with more favorable clinical outcomes. Be-
cause of its less invasive nature and quicker recov-
ery times, however, PCI is often presumed more
desirable than bypass surgery among older patients,
even if the possibility of complete revascularization
must be sacrificed. While a widely held assumption
exists that less invasive therapies may be prefera-
ble for elderly individuals, examples to the contra-
ry exist.
For instance, carotid stenting has gained ac-
ceptance as a safe and effective less invasive alter-
native to carotid endarterectomy for carotid artery
revascularization among individuals at higher sur-
gical risk. It was initially assumed that the benefits
of carotid stenting would be especially robust among
the elderly patients. Emerging data from a number
of trials of carotid stenting, however, have shown
this assumption to be flawed. While the results of
carotid stenting appear favorable in younger indi-
viduals, there is a sharp and consistent increase the
incidence of major complications among octogenar-
ians undergoing carotid stent placement, which
appears to far outstrip the less dramatic age-related
increase in procedural risk that accompanies
carotid endarterectomy [10]. The age-related
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increase in complications with carotid stenting is
likely related to anatomic and lesion-related factors
that accompany aging, such as increased aortic arch
and carotid calcification and tortuosity, which make
catheter manipulation within the vasculature more
difficult. Overall, as it becomes more evident that
older patients can respond quite differently than
younger individuals to various therapies, the impor-
tance of performing dedicated therapeutic trials
among elderly patients is apparent.
Economic implications
With an ever-increasing number of elderly in-
dividuals seeking medical attention for coronary
artery disease, economic issues must also be con-
sidered. Medical care for the elderly accounts for
a large percentage of total health care costs, and
evidence for the utility of many therapies employed
near the end of life is often lacking. It has been
noted that in the United States, 30% of all Medicare
(government health insurance for individuals
‡ 65 years old) expenditures are consumed in the
final year of life [11]. Consequently, avoidance of
costly procedures that are not associated with clin-
ical benefit is clearly desirable for both individual
patients and society as a whole.
Because the performance of an increasing
number of invasive procedures, such as PCI, could
potentially place a greater economic burden on so-
cieties, it is especially essential to identify the spe-
cific groups of elderly individuals for whom PCI is
indeed superior to more conservative strategies.
An analysis of patients aged 75 years or greater
who were enrolled in a prospective Swiss trial of
PCI versus medical therapy did suggest that PCI
could lead to improved clinical outcomes at only
minimally increased economic costs, but further
study is needed [12].
Conclusions
Given their heightened comorbidity profiles,
tendency toward more difficult coronary anatomy,
and shorter life expectancies, ideal strategies to
treat coronary disease in older individuals may vary
substantially from algorithms established in young-
er patients. Evidence-based guidelines for the treat-
ment of older individuals remain woefully inade-
quate. These deficiencies are compounded by a lack
of common agreement over the age at which a per-
son should be considered elderly, with various
arbitrary age cutoffs ranging from 65 to 85 years
used among published studies. Indeed, as humor-
ously alluded to by Bernard Baruchs quotation at
the outset of this editorial, no universal cut-point
can ever exist to define the onset of old age, as
a persons chronological age does not always cor-
relate with their so-called physiological age.
Nevertheless, advanced age unquestionably
represents a potent risk factor for adverse outcomes
among patients with coronary artery disease, and
merits special attention. Given the increasing av-
erage age of patients seeking treatment for coro-
nary disease, the time is ideal for the performance
of dedicated prospective trials examining the rela-
tive merits of medical therapies, PCI and coronary
artery by-pass grafting among older individuals.
Such studies are essential to better define the risks,
benefits, and costs of these options in this unique
patient group. Until more data becomes available
(and even after it does), treatment recommenda-
tions among the elderly will likely always remain
highly individualized, with a heavy reliance on phy-
sician judgment and experience, as well as the in-
dividual patients desires for a more or less inva-
sive treatment approach.
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